Effect of Barberry on Non Alcoholic
Phase 2
- Conditions
- on-alcoholic Steatohepatitis.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT201202068505N2
- Lead Sponsor
- Vice Chancellor for Research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Including criteria : older than 20 years with nonalcoholic- fatty liver disease; liver enzymes>42 and proportion of ALT/ AST>1. Excluding criteria : using drugs that affect liver tests during the last 2 months; viral hepatitis; hemochromatosis; autoimmune hepatitis; cirrhosis;type 1 diabetes; alcohol dependency; pregnancy; breast feeding and infectious diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT. Timepoint: Before, 45 days and 3 month after the therapy. Method of measurement: Laboratory.;AST. Timepoint: Before, 45 days and 3 month after the therapy. Method of measurement: Laboratory.;FBS. Timepoint: Before, 45 days and 3 month after the therapy. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Chol-T. Timepoint: Before and 3 months after the therapy. Method of measurement: laboratory.;Triglycirid. Timepoint: Before and 3 months after the therapy. Method of measurement: laboratory.;LDL. Timepoint: Before and 3 months after the therapy. Method of measurement: laboratory.;HDL. Timepoint: Before and 3 months after the therapy. Method of measurement: laboratory.